Morgan Stanley’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.9K | Sell |
|
|||||
|
2025
Q1 | $61.9K | Buy |
|
|||||
|
2024
Q4 | $129K | Buy |
|
|||||
|
2024
Q3 | $1.16K | Buy |
|
|||||
|
2024
Q2 | $1.16K | Hold |
|
|||||
|
2024
Q1 | $3.23K | Sell |
|
|||||
|
2023
Q4 | $2.66K | Buy |
|
|||||
|
2023
Q3 | $1.49K | Sell |
|
|||||
|
2023
Q2 | $2.91K | Sell |
|
|||||
|
2023
Q1 | $116K | Buy |
|
|||||
|
2022
Q4 | $2.24K | Sell |
|
|||||
|
2022
Q3 | $11K | Sell |
|
|||||
|
2022
Q2 | $64K | Sell |
|
|||||
|
2022
Q1 | $171K | Buy |
|
|||||
|
2021
Q4 | $613K | Sell |
|
|||||
|
2021
Q3 | $7.28M | Buy |
|
|||||
|
2021
Q2 | $324K | Sell |
|
|||||
|
2021
Q1 | $780K | Buy |
|
|||||
|
2020
Q4 | $570K | Buy |
|